Patients with HCC exhibiting upregulated PKM and PFKM expression levels were associated with increased cumulative recurrence rates when compared with those exhibiting downregulated PKM expression levels [17, 19]. This evidence concerns the gene PFKM and hepatocellular carcinoma.